Tuvonralima b
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tuvonralima b, covering 2025-06-25 to 2025-06-25. Get the full timeline:
Most recent: Clinical Trial Update: a Single Arm, Phase II Multicenter Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of Iparomlimab and Tuvonralima b and Chemotherapy ± Bevacizumab Induction Therapy Followed by Concurrent Chemoradiotherapy in Patients With Advanced Cervical Cancer . [Phase 2]